Cargando…
Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review
Precision diagnostic testing (PDT) employs appropriate biomarkers to identify cancer patients that may optimally respond to precision medicine (PM) approaches, such as treatments with targeted agents and immuno‐oncology drugs. To date, there are no published systematic appraisals evaluating the cost...
Autores principales: | Henderson, Raymond, Keeling, Peter, French, Declan, Smart, Dave, Sullivan, Richard, Lawler, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486593/ https://www.ncbi.nlm.nih.gov/pubmed/34110679 http://dx.doi.org/10.1002/1878-0261.13038 |
Ejemplares similares
-
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach
por: Henderson, Raymond H., et al.
Publicado: (2023) -
Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analyses
por: Henderson, Raymond, et al.
Publicado: (2019) -
Precision Medicine in Oral Health and Diseases: A Systematic Review
por: Malcangi, Giuseppina, et al.
Publicado: (2023) -
Precision Medicine on the Effects of Microbiota on Head–Neck Diseases and Biomarkers Diagnosis
por: Inchingolo, Angelo Michele, et al.
Publicado: (2023) -
Accounting for Capacity Constraints in Economic Evaluations of Precision Medicine: A Systematic Review
por: Wright, Stuart J., et al.
Publicado: (2019)